Jun 25, 2015 7:05am EDT

Immunovaccine Collaborates With Incyte to Evaluate Novel Immunotherapy Combination for Patients With Platinum-Sensitive Ovarian Cancer

May 21, 2015 7:05am EDT

Immunovaccine to Present at Upcoming Investor Conferences

May 12, 2015 5:05pm EDT

Immunovaccine Announces Financial Results For Quarter Ended March 31, 2015

Apr 27, 2015 7:05am EDT

Immunovaccine Joins the OTCQX Marketplace in the United States

Apr 16, 2015 5:05pm EDT

Immunovaccine Provides Corporate Update and AGM Results

Apr 15, 2015 7:05am EDT

Immunovaccine to Present at American Association for Cancer Research (AACR) 2015 Annual Meeting

Mar 31, 2015 7:00am EDT

Immunovaccine to Present at World Vaccine Congress 2015

Mar 24, 2015 7:00am EDT

Immunovaccine Initiates Phase 2 Clinical Trial of DPX-Survivac Immunotherapy in Recurrent Lymphoma

Mar 20, 2015 4:30pm EDT

Immunovaccine Announces 2014 Year-End Results

Mar 16, 2015 7:00am EDT

Immunovaccine Announces Intent to Trade on OTCQX Marketplace in United States